Martingale Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-44,506
Closed -$3.55M 938
2020
Q3
$3.55M Buy
44,506
+20,350
+84% +$1.59M 0.04% 282
2020
Q2
$1.67M Buy
+24,156
New +$1.72M 0.02% 589
2019
Q1
Sell
-126,621
Closed -$6.47M 1020
2018
Q4
$6.47M Sell
126,621
-106,215
-46% -$5.37M 0.09% 244
2018
Q3
$13.5M Sell
232,836
-38,694
-14% -$1.89M 0.16% 163
2018
Q2
$13.2M Sell
271,530
-105,537
-28% -$4.93M 0.16% 167
2018
Q1
$17.5M Buy
+377,067
New +$16.4M 0.23% 140
2015
Q4
Sell
-16,212
Closed -$385K 841
2015
Q3
$385K Sell
16,212
-540,234
-97% -$13M 0.01% 700
2015
Q2
$13.2M Sell
556,446
-187,824
-25% -$4.24M 0.31% 107
2015
Q1
$17.7M Buy
744,270
+213,288
+40% +$4.78M 0.42% 59
2014
Q4
$11.3M Buy
530,982
+428,622
+419% +$8.61M 0.31% 94
2014
Q3
$1.74M Buy
+102,360
New +$1.62M 0.05% 321

Other funds holding EW

Martingale Asset Management's EW Position: Q4 2020 in Review

Martingale Asset Management sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 44,506 shares — an estimated $3.55M sold.

Martingale Asset Management first reported a position in EW in Q3 2014 and held it in 11 quarters. The position peaked at $17.7M in Q1 2015. 1,160 funds tracked by Wall St. Rank hold EW as of Q4 2020.

  • Martingale Asset Management reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
  • Martingale Asset Management sold 44,506 Edwards Lifesciences shares in Q4 2020, an estimated $3.55M.
  • Martingale Asset Management first reported a position in Edwards Lifesciences in Q3 2014 and held it in 11 quarters.
  • Martingale Asset Management's Edwards Lifesciences position peaked at $17.7M in Q1 2015.
  • 1,160 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on Martingale Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.